What is the recommended dosing of trazodone for an adult patient with a history of depression or nicotine addiction, taking bupropion, who is experiencing insomnia or sleep disturbances?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Trazodone Dosing for Insomnia in Adults on Bupropion

For insomnia in an adult taking bupropion, start trazodone at 25-50 mg at bedtime, though major sleep medicine guidelines recommend against trazodone as first-line therapy and suggest FDA-approved hypnotics or cognitive behavioral therapy instead. 1, 2

Critical Context: Guidelines Recommend Against Trazodone

  • The American Academy of Sleep Medicine explicitly recommends AGAINST using trazodone for sleep onset or sleep maintenance insomnia, giving it a "WEAK" recommendation based on trials showing only modest improvements in sleep parameters with no significant improvement in subjective sleep quality at 50 mg doses 1, 2
  • The Department of Veterans Affairs/Department of Defense guidelines similarly advise against trazodone for chronic insomnia disorder 1
  • The benefits do not outweigh potential harms including daytime drowsiness, dizziness, psychomotor impairment, and rare but serious effects like priapism 1, 2

Recommended Treatment Algorithm

First-Line Treatment:

  • Cognitive behavioral therapy for insomnia (CBT-I) should be the initial treatment, including stimulus control therapy, sleep restriction therapy, and relaxation techniques 1, 2

Second-Line Pharmacologic Options:

  • For sleep onset AND maintenance: Eszopiclone 2-3 mg, zolpidem 10 mg, or temazepam 15 mg 1, 2
  • For sleep onset only: Zaleplon 10 mg, ramelteon 8 mg, or triazolam 0.25 mg 1, 2
  • For sleep maintenance only: Suvorexant or doxepin 3-6 mg 1, 2

Third-Line: Trazodone (When Appropriate)

Trazodone may be considered only after first and second-line treatments have failed, or when comorbid depression is present 1, 2

Specific Dosing When Trazodone Is Used

Standard Dosing for Insomnia:

  • Start with 25-50 mg at bedtime (lower than antidepressant doses) 3, 1
  • The NCCN palliative care guidelines specifically recommend trazodone 25-100 mg PO at bedtime for insomnia 3
  • Take shortly after a meal or light snack to optimize absorption 4
  • These low doses are below the therapeutic antidepressant range and inadequate for treating major depression 1, 2

FDA-Approved Antidepressant Dosing (For Reference):

  • Initial dose: 150 mg/day in divided doses 4
  • May increase by 50 mg/day every 3-4 days 4
  • Maximum outpatient dose: 400 mg/day in divided doses 4
  • Inpatient maximum: 600 mg/day in divided doses 4

Special Considerations for Patients on Bupropion

Potential Benefits of This Combination:

  • Trazodone can effectively treat antidepressant-associated insomnia in patients taking bupropion, with 67% of patients experiencing overall improvement in sleep versus 13% with placebo in a controlled trial 5
  • Bupropion commonly causes insomnia as a side effect, making this a clinically relevant scenario 6, 7
  • The combination may be particularly appropriate if the patient has comorbid depression or nicotine addiction, as bupropion is FDA-approved for both conditions 3, 6, 7

Drug Interaction Considerations:

  • Bupropion is a potent enzyme inhibitor that can raise plasma levels of other drugs 7
  • However, no specific contraindication exists for combining bupropion with trazodone 5
  • Monitor for excessive sedation, as one patient in clinical trials discontinued trazodone due to daytime sedation 5

Timing Optimization:

  • Administer bupropion's second dose no later than 6 hours before bedtime to minimize insomnia risk 3
  • Give trazodone at bedtime to maximize sleep benefits while minimizing daytime drowsiness 3, 8

Important Safety Warnings

Contraindications and Cautions:

  • Avoid in patients with seizure disorders or factors that lower seizure threshold, as bupropion already increases seizure risk 3, 9
  • Avoid in pregnancy and nursing 1
  • Use caution in elderly patients and consider dose reduction 1, 2
  • Avoid in patients with compromised respiratory function, hepatic or heart failure 1
  • Do not combine with MAOIs; allow at least 14 days between discontinuation of MAOI and starting trazodone 4

Common Pitfalls to Avoid:

  • Do not use trazodone as first-line therapy for primary insomnia 1, 2
  • Do not combine two sedating antidepressants due to risks of serotonin syndrome, excessive sedation, and QTc prolongation 2
  • Do not prescribe trazodone without attempting CBT-I or FDA-approved hypnotics first 1, 2
  • Do not use over-the-counter antihistamines or herbal supplements as alternatives due to lack of efficacy and safety data 1, 2

Mandatory Patient Education and Follow-Up

Patient Counseling:

  • Discuss treatment goals, safety concerns, and potential side effects including daytime drowsiness and psychomotor impairment 1, 2
  • Advise taking on an empty stomach to maximize effectiveness 1
  • Allow appropriate sleep time (7-8 hours) after taking medication 1
  • Warn about potential sleep behaviors (sleepwalking, sleep driving) 1

Follow-Up Requirements:

  • Assess effectiveness and side effects every few weeks initially 1, 2
  • Use the lowest effective maintenance dose 1, 2
  • Taper medication gradually when conditions allow rather than stopping abruptly 1, 2, 4
  • Consider discontinuation if no benefit after adequate trial 1, 2

Clinical Bottom Line

While trazodone 25-50 mg at bedtime can effectively treat insomnia in patients taking bupropion 5, major sleep medicine guidelines recommend trying CBT-I and FDA-approved hypnotics first 1, 2. Trazodone is most appropriate as a third-line agent when comorbid depression exists or when first and second-line treatments have failed 1, 2.

References

Guideline

Trazodone for Insomnia Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Trazodone for Insomnia Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Trazodone for antidepressant-associated insomnia.

The American journal of psychiatry, 1994

Research

Other Antidepressants.

Handbook of experimental pharmacology, 2019

Research

The use of bupropion SR in cigarette smoking cessation.

International journal of chronic obstructive pulmonary disease, 2008

Research

Trazodone dosing regimen: experience with single daily administration.

The Journal of clinical psychiatry, 1990

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.